Register Free at http://pharmtech.com/winning

Event Overview:
The regulatory pathway to FDA approval for topical products may differ from those available for other therapeutic areas. “Winning Regulatory Strategies and Opportunities in Dermatology” & “From First in Humans to Commercialization” provides multiple silver bullets that must be considered when developing both clinical and nonclinical strategies and plans. This webcast is sponsored by Dow Pharmaceutical Sciences, Inc. - The world’s leading prescription topical product development company. If you’re involved in topical product development, this is the one webcast you must attend!

Event Teaser appearing in e-solutions mailings

• Looking for a deeper understanding of the unique regulatory aspects involved in topical product development?
• Are you familiar with the unique nonclinical requirements for topical drug development?
• Looking for answers to these questions or involved in topical product development? This is the one webcast you can’t afford to miss!

Key Learning Objectives:

• Develop an understanding of the unique regulatory aspects for topical dermatologics
• Understand the unique nonclinical requirements for topical drug development
• Review case studies of nonclinical 505(b)(2) NDAs